These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 31299378)

  • 1. Evaluation of 5-hydroxy-1,4-naphthoquinone-cobalt(III) complexes for hypoxia-activated drug delivery.
    de Mello MVP; Cebrián-Torrejón G; Pereira JR; Dos Santos Moreira C; Gomes CBSMR; da Rocha DR; de Souza Fagundes EM; Ferreira GB; Lanznaster M
    J Inorg Biochem; 2019 Oct; 199():110756. PubMed ID: 31299378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A study on the properties and reactivity of naphthoquinone-cobalt(III) prototypes for bioreductive prodrugs.
    Bustamante FL; Miranda FS; Castro FA; Resende JA; Pereira MD; Lanznaster M
    J Inorg Biochem; 2014 Mar; 132():37-44. PubMed ID: 24326134
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of cobalt(III) complexes as potential hypoxia-responsive carriers of esculetin.
    Palmeira-Mello MV; Caballero AB; Ribeiro JM; de Souza-Fagundes EM; Gamez P; Lanznaster M
    J Inorg Biochem; 2020 Oct; 211():111211. PubMed ID: 32805459
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cross-bridged cyclen or cyclam Co(III) complexes containing cytotoxic ligands as hypoxia-activated prodrugs.
    Chang JY; Lu GL; Stevenson RJ; Brothers PJ; Clark GR; Botting KJ; Ferry DM; Tercel M; Wilson WR; Denny WA; Ware DC
    Inorg Chem; 2013 Jul; 52(13):7688-98. PubMed ID: 23773210
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigation of cobalt(iii)-triazole systems as prototypes for hypoxia-activated drug delivery.
    de Souza IC; Faro LV; Pinheiro CB; Gonzaga DT; da Silva Fde C; Ferreira VF; Miranda Fda S; Scarpellini M; Lanznaster M
    Dalton Trans; 2016 Sep; 45(35):13671-4. PubMed ID: 27488398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Towards targeting anticancer drugs: ruthenium(ii)-arene complexes with biologically active naphthoquinone-derived ligand systems.
    Kubanik M; Kandioller W; Kim K; Anderson RF; Klapproth E; Jakupec MA; Roller A; Söhnel T; Keppler BK; Hartinger CG
    Dalton Trans; 2016 Aug; 45(33):13091-103. PubMed ID: 27214822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cobalt complexes bearing scorpionate ligands: synthesis, characterization, cytotoxicity and DNA cleavage.
    Silva TF; Martins LM; Guedes da Silva MF; Fernandes AR; Silva A; Borralho PM; Santos S; Rodrigues CM; Pombeiro AJ
    Dalton Trans; 2012 Nov; 41(41):12888-97. PubMed ID: 22986733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bis(dialkyl)dithiocarbamato cobalt(III) complexes of bidentate nitrogen mustards: synthesis, reduction chemistry and biological evaluation as hypoxia-selective cytotoxins.
    Ware DC; Palmer HR; Pruijn FB; Anderson RF; Brothers PJ; Denny WA; Wilson WR
    Anticancer Drug Des; 1998 Mar; 13(2):81-103. PubMed ID: 9524553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis, characterization and cytotoxicity studies of Co(III)-flavonolato complexes.
    Kozsup M; Zhou X; Farkas E; Bényei AC; Bonnet S; Patonay T; Kónya K; Buglyó P
    J Inorg Biochem; 2021 Apr; 217():111382. PubMed ID: 33588278
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Copper(II), cobalt(II) and nickel(II) complexes of juglone: synthesis, structure, DNA interaction and enhanced cytotoxicity.
    Tabrizi L; Fooladivanda M; Chiniforoshan H
    Biometals; 2016 Dec; 29(6):981-993. PubMed ID: 27613275
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A series of mononuclear Co(III) complexes using tridentate N,O-donor ligands: chemical properties and cytotoxicity activity.
    Souza ET; Maia PJ; Azevedo EM; Kaiser CR; Resende JA; Pinheiro CB; Heinrich TA; da Silva RS; Scarpellini M
    J Inorg Biochem; 2011 Dec; 105(12):1767-73. PubMed ID: 22001498
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cobalt complexes with pyrazole ligands as catalyst precursors for the peroxidative oxidation of cyclohexane: X-ray absorption spectroscopy studies and biological applications.
    Silva TF; Martins LM; Guedes da Silva MF; Kuznetsov ML; Fernandes AR; Silva A; Pan CJ; Lee JF; Hwang BJ; Pombeiro AJ
    Chem Asian J; 2014 Apr; 9(4):1132-43. PubMed ID: 24482364
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Investigation of cobalt(III)-phenylalanine complexes for hypoxia-activated drug delivery.
    de Souza ICA; Santana SS; Gómez JG; Guedes GP; Madureira J; Quintal SMO; Lanznaster M
    Dalton Trans; 2020 Nov; 49(45):16425-16439. PubMed ID: 32692333
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimization of the auxiliary ligand shell of Cobalt(III)(8-hydroxyquinoline) complexes as model hypoxia-selective radiation-activated prodrugs.
    Ahn GO; Ware DC; Denny WA; Wilson WR
    Radiat Res; 2004 Sep; 162(3):315-25. PubMed ID: 15333003
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cobalt(III) complexes as potential anticancer agents: Physicochemical, structural, cytotoxic activity and DNA/protein interactions.
    Thamilarasan V; Sengottuvelan N; Sudha A; Srinivasan P; Chakkaravarthi G
    J Photochem Photobiol B; 2016 Sep; 162():558-569. PubMed ID: 27475779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improving the Stability of EGFR Inhibitor Cobalt(III) Prodrugs.
    Mathuber M; Schueffl H; Dömötör O; Karnthaler C; Enyedy ÉA; Heffeter P; Keppler BK; Kowol CR
    Inorg Chem; 2020 Dec; 59(23):17794-17810. PubMed ID: 33222438
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Physical properties, ligand substitution reactions, and biological activity of Co(iii)-Schiff base complexes.
    King AP; Gellineau HA; MacMillan SN; Wilson JJ
    Dalton Trans; 2019 May; 48(18):5987-6002. PubMed ID: 30672949
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anionic Dinuclear Oxidovanadium(IV) Complexes with Azo Functionalized Tridentate Ligands and μ-Ethoxido Bridge Leading to an Unsymmetric Twisted Arrangement: Synthesis, X-ray Structure, Magnetic Properties, and Cytotoxicity.
    Roy S; Böhme M; Dash SP; Mohanty M; Buchholz A; Plass W; Majumder S; Kulanthaivel S; Banerjee I; Reuter H; Kaminsky W; Dinda R
    Inorg Chem; 2018 May; 57(10):5767-5781. PubMed ID: 29741373
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis, characterization and biological activities of mononuclear Co(III) complexes as potential bioreductively activated prodrugs.
    Souza ET; Castro LC; Castro FA; do Canto Visentin L; Pinheiro CB; Pereira MD; de Paula Machado S; Scarpellini M
    J Inorg Biochem; 2009 Oct; 103(10):1355-65. PubMed ID: 19665800
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Syntheses of 8-quinolinolatocobalt(III) complexes containing cyclen based auxiliary ligands as models for hypoxia-activated prodrugs.
    Chang JY; Stevenson RJ; Lu GL; Brothers PJ; Clark GR; Denny WA; Ware DC
    Dalton Trans; 2010 Dec; 39(48):11535-50. PubMed ID: 21103540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.